{
  "report_rows": [
    {
      "kpi": "Q2 2026 revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.315B vs. cons $1.300B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$6.72 vs. cons $6.58",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 organic revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~10.5% vs. cons 10.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$5.34B vs. cons $5.31B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$27.20 vs. cons $26.90 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 revenue guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.35B vs. cons $1.35B (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$6.80 vs. cons $6.67 (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~10.0% vs. cons 10.0% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 5.2,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A FY2026 adjusted EPS guide of ~$27.20 versus consensus ~$26.90 implies second-half adjusted EPS of roughly $14.68 after predicted first-half EPS of $12.52, above the approximately $14.38 embedded in consensus; positive estimate revisions should outweigh the elevated pre-earnings valuation.",
  "day5_confidence": "MEDIUM"
}